<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="develop">
            <roleset id="develop.01" name="" wordnet="10">
                <roles>
                    <role n="0" descr="non-intentional theme&#x0A;" />
                    <role n="1" descr="thing developed&#x0A;" />
                    <role n="2" descr="end result&#x0A;" />
                </roles>
                <example src="ARCHIVE" no="0">
                    <text>Although Pin1 -/- mice are able to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="1">
                    <text>Although Pin1 -/- mice are believed to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="2">
                    <text>Although Pin1 -/- mice are believed to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="3">
                    <text>Although Pin1 -/- mice are found to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="4">
                    <text>Although Pin1 -/- mice are found to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="5">
                    <text>Although Pin1 -/- mice are predicted to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="6">
                    <text>Although Pin1 -/- mice are predicted to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="7">
                    <text>Although Pin1 -/- mice are previously able to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="8">
                    <text>Although Pin1 -/- mice are previously believed to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="9">
                    <text>Although Pin1 -/- mice are previously believed to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="10">
                    <text>Although Pin1 -/- mice are previously found to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="11">
                    <text>Although Pin1 -/- mice are previously found to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="12">
                    <text>Although Pin1 -/- mice are previously predicted to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="13">
                    <text>Although Pin1 -/- mice are previously predicted to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="14">
                    <text>Although Pin1 -/- mice are previously shown to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="15">
                    <text>Although Pin1 -/- mice are previously shown to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="16">
                    <text>Although Pin1 -/- mice are shown to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="17">
                    <text>Although Pin1 -/- mice are shown to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="18">
                    <text>Although Pin1 -/- mice can develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="19">
                    <text>Although Pin1 -/- mice can have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="20">
                    <text>Although Pin1 -/- mice can have previously developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="21">
                    <text>Although Pin1 -/- mice can previously develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="22">
                    <text>Although Pin1 -/- mice could develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="23">
                    <text>Although Pin1 -/- mice could previously develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="24">
                    <text>Although Pin1 -/- mice have been believed to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="25">
                    <text>Although Pin1 -/- mice have been believed to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="26">
                    <text>Although Pin1 -/- mice have been found to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="27">
                    <text>Although Pin1 -/- mice have been found to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="28">
                    <text>Although Pin1 -/- mice have been predicted to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="29">
                    <text>Although Pin1 -/- mice have been predicted to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="30">
                    <text>Although Pin1 -/- mice have been shown to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="31">
                    <text>Although Pin1 -/- mice have been shown to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="32">
                    <text>Although Pin1 -/- mice have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="33">
                    <text>Although Pin1 -/- mice have previously been believed to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="34">
                    <text>Although Pin1 -/- mice have previously been believed to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="35">
                    <text>Although Pin1 -/- mice have previously been found to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="36">
                    <text>Although Pin1 -/- mice have previously been found to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="37">
                    <text>Although Pin1 -/- mice have previously been predicted to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="38">
                    <text>Although Pin1 -/- mice have previously been predicted to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="39">
                    <text>Although Pin1 -/- mice have previously been shown to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="40">
                    <text>Although Pin1 -/- mice have previously been shown to have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="41">
                    <text>Although Pin1 -/- mice have previously developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="42">
                    <text>Although Pin1 -/- mice may develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="43">
                    <text>Although Pin1 -/- mice may have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="44">
                    <text>Although Pin1 -/- mice may have previously developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="45">
                    <text>Although Pin1 -/- mice may previously develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="46">
                    <text>Although Pin1 -/- mice might develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="47">
                    <text>Although Pin1 -/- mice might previously develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="48">
                    <text>Although Pin1 -/- mice were able to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="49">
                    <text>Although Pin1 -/- mice were believed to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="50">
                    <text>Although Pin1 -/- mice were found to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="51">
                    <text>Although Pin1 -/- mice were predicted to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="52">
                    <text>Although Pin1 -/- mice were previously able to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="53">
                    <text>Although Pin1 -/- mice were previously believed to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="54">
                    <text>Although Pin1 -/- mice were previously found to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="55">
                    <text>Although Pin1 -/- mice were previously predicted to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="56">
                    <text>Although Pin1 -/- mice were previously shown to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="57">
                    <text>Although Pin1 -/- mice were shown to develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="58">
                    <text>Although Pin1 -/- mice will develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="59">
                    <text>Although Pin1 -/- mice will have developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="60">
                    <text>Although Pin1 -/- mice will have previously developed normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="61">
                    <text>Although Pin1 -/- mice will previously develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="62">
                    <text>Although Pin1 -/- mice would develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="63">
                    <text>Although Pin1 -/- mice would previously develop normally (Fujimori et al., 1999), we have uncovered that they display a range of cell proliferative abnomalities, including decreased body size, retinal degenration and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="ARCHIVE" no="64">
                    <text>Three new mutations, two missense and one nonsense, were detected: (1) a C-to-T transition in codon 44 in exon 2 replacing a threonine by an isoleucine (T44I) was found in a late-onset symptomatic female patient but not in her asymptomatic mother; (2) a C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son developed acute neonatal onset of OTC deficiency; (3) a C-to-T transition in codon 320 (arginine) abolishing a TaqI recognition site and creating a new BclI site in exon 9 with generation of a stop codon (R320X) leading to premature termination in the enzyme.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="ARCHIVE" no="65">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we are able to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="66">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we are ready to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="67">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we can develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="68">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we can have developed a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="69">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we choose to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="70">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we chose to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="71">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we could develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="72">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we decide to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="73">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we decided to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="74">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="75">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we developed a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="76">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we had the ability to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="77">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we have been able to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="78">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we have been ready to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="79">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we have chosen to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="80">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we have decided to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="81">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we have developed a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="82">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we have the ability to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="83">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we may develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="84">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we may have developed a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="85">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we might develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="86">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we were able to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="87">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we were ready to develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="88">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we will develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="89">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we will have developed a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="ARCHIVE" no="90">
                    <text>To isolate cDNA clones that dominantly inhibit the DNA-binding activity of Oct-2, chosen as a representative factor, we would develop a novel screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a novel screening system</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Spinach sown in October being able to develop into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Spinach sown in October can develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Spinach sown in October can have developed into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Spinach sown in October could develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Spinach sown in October developed into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Spinach sown in October developing into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Spinach sown in October develops into tthe rosette stage and grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Spinach sown in October had the ability to develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Spinach sown in October has been developing into he rosette stage and can grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Spinach sown in October has developed into he rosette stage and grown through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Spinach sown in October has the ability to develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Spinach sown in October is able to develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Spinach sown in October is believed to develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Spinach sown in October is developing into he rosette stage and will grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Spinach sown in October is found to develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Spinach sown in October is predicted to develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Spinach sown in October is shown to develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Spinach sown in October may develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>Spinach sown in October may have developed into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>Spinach sown in October might develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Spinach sown in October that can develop into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Spinach sown in October that develops into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Spinach sown in October that is able to develop into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>Spinach sown in October was able to develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>Spinach sown in October was believed to develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>Spinach sown in October was found to develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>Spinach sown in October was predicted to develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>Spinach sown in October was shown to develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>Spinach sown in October which can develop into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>Spinach sown in October which develops into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>Spinach sown in October which is able to develop into he rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>Spinach sown in October will develop into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>Spinach sown in October will have developed into he rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Spinach sown in October would develop into he rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="SEED" no="1">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son can develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="2">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son can have developed acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="3">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son develops acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="4">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son has the ability to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="5">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son has the risk of developing acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="6">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son is able to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="7">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son is believed to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="8">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son is developing acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="9">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son is found to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="10">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son is observed to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="11">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son is predicted to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="12">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son is shown to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="13">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son may develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="14">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son may have developed acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="15">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son will develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="16">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) is identified in an asymptomatic female carrier whose son will have developed acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="17">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son could develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="18">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son had the ability to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="19">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son had the risk of developing acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="20">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son has been developing acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="21">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son has developed acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="22">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son might develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="23">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son was believed to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="24">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son was developing acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="25">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son was found to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="26">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son was observed to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="27">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son was predicted to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="28">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son was shown to develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="29">
                    <text>A C-to-T transition in codon 214 creating a new RsaI recognition site in exon 6 and substituting tyrosine for histidine (H214Y) was identified in an asymptomatic female carrier whose son would develop acute neonatal onset of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal onset of OTC deficiency</arg>
                </example>
                <example src="SEED" no="30">
                    <text>It has been planted from September up to the end of October, and has been observed to develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="31">
                    <text>It has been planted from September up to the end of October, and has developed into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="32">
                    <text>It is planted from September up to the end of October, and can develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="33">
                    <text>It is planted from September up to the end of October, and can obviously develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="34">
                    <text>It is planted from September up to the end of October, and develops into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="35">
                    <text>It is planted from September up to the end of October, and has the ability to develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="36">
                    <text>It is planted from September up to the end of October, and is able to develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="37">
                    <text>It is planted from September up to the end of October, and is believed to develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="38">
                    <text>It is planted from September up to the end of October, and is predicted to develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="39">
                    <text>It is planted from September up to the end of October, and may develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="40">
                    <text>It is planted from September up to the end of October, and may obviously develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="41">
                    <text>It is planted from September up to the end of October, and will be shown to develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="42">
                    <text>It is planted from September up to the end of October, develops into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="43">
                    <text>It will be planted from September up to the end of October, and will develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="44">
                    <text>It will be planted from September up to the end of October, and will obviously develop into the rosette stage and keeps on growing until the end of November.</text>
                    <arg n="0">It</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="45">
                    <text>Spinach sown in October being able to develop into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="46">
                    <text>Spinach sown in October can develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="47">
                    <text>Spinach sown in October can have developed into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="48">
                    <text>Spinach sown in October could develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="49">
                    <text>Spinach sown in October developed into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="50">
                    <text>Spinach sown in October developing into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="51">
                    <text>Spinach sown in October develops into the rosette stage and grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">he rosette stage</arg>
                </example>
                <example src="SEED" no="52">
                    <text>Spinach sown in October had the ability to develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="53">
                    <text>Spinach sown in October has been developing into the rosette stage and can grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="54">
                    <text>Spinach sown in October has developed into the rosette stage and grown through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="55">
                    <text>Spinach sown in October has the ability to develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="56">
                    <text>Spinach sown in October is able to develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="57">
                    <text>Spinach sown in October is believed to develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="58">
                    <text>Spinach sown in October is developing into the rosette stage and will grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="59">
                    <text>Spinach sown in October is found to develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="60">
                    <text>Spinach sown in October is predicted to develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="61">
                    <text>Spinach sown in October is shown to develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="62">
                    <text>Spinach sown in October may develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="63">
                    <text>Spinach sown in October may have developed into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="64">
                    <text>Spinach sown in October might develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="65">
                    <text>Spinach sown in October that can develop into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="66">
                    <text>Spinach sown in October that develops into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="67">
                    <text>Spinach sown in October that is able to develop into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="68">
                    <text>Spinach sown in October was able to develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="69">
                    <text>Spinach sown in October was believed to develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="70">
                    <text>Spinach sown in October was found to develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="71">
                    <text>Spinach sown in October was predicted to develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="72">
                    <text>Spinach sown in October was shown to develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="73">
                    <text>Spinach sown in October which can develop into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="74">
                    <text>Spinach sown in October which develops into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="75">
                    <text>Spinach sown in October which is able to develop into the rosette stage grows through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="76">
                    <text>Spinach sown in October will develop into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="77">
                    <text>Spinach sown in October will have developed into the rosette stage and grow through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="SEED" no="78">
                    <text>Spinach sown in October would develop into the rosette stage and grew through the end of November.</text>
                    <arg n="1">Spinach sown in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
